Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Inogen Inc is a medical devices business based in the US. Inogen shares (INGN) are listed on the NASDAQ and all prices are listed in US Dollars. Inogen employs 938 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $29.01 |
|---|---|
| 52-week range | $26.19 - $82.35 |
| 50-day moving average | $32.47 |
| 200-day moving average | $52.03 |
| Wall St. target price | $44.00 |
| PE ratio | 60.3181 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.50 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $29.01 from 2022-01-27
| 1 week (2022-01-19) | -4.70% |
|---|---|
| 1 month (2021-12-27) | -13.45% |
| 3 months (2021-10-28) | -26.61% |
| 6 months (2021-07-28) | -62.26% |
| 1 year (2021-01-28) | -40.66% |
|---|---|
| 2 years (2020-01-28) | -37.80% |
| 3 years (2019-01-28) | 145.71 |
| 5 years (2017-01-27) | 65.08 |
Valuing Inogen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inogen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Inogen's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 60x. In other words, Inogen shares trade at around 60x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Inogen's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.48. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Inogen's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Inogen's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $24.4 million.
The EBITDA is a measure of a Inogen's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $355.6 million |
|---|---|
| Operating margin TTM | 1.01% |
| Gross profit TTM | $138.2 million |
| Return on assets TTM | 0.46% |
| Return on equity TTM | 3.07% |
| Profit margin | 3.21% |
| Book value | $17.21 |
| Market capitalisation | $689.4 million |
TTM: trailing 12 months
We're not expecting Inogen to pay a dividend over the next 12 months.
Over the last 12 months, Inogen's shares have ranged in value from as little as $26.19 up to $82.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inogen's is 0.964. This would suggest that Inogen's shares are less volatile than average (for this exchange).
Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Five major factors contribute to the continued bull run of Bitcoin, ARK says, including growing adoption and long-term focus of investors.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
